Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Heiko Smetak"'
Autor:
Jessica C. Hassel, Timo E. Schank, Heiko Smetak, Jasmin Mühlbauer, Martin Salzmann, Devayani Machiraju, Christian Menzer, Kristin Lang, Laila König, Matthias F. Haefner, Ingrid Hülsmeyer, Christian Kohler, Rainer Spang, Alexander Enk, Jürgen Debus, Philipp Beckhove
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
In patients with melanoma brain metastases (MBM), a combination of radiotherapy (RT) with immune checkpoint inhibitors (ICI) is routinely used. However, the best sequence of radio-immunotherapy (RIT) remains unclear. In an exploratory phase 2 trial,
Externí odkaz:
https://doaj.org/article/5c11e7dab9974230b5dc3d9f87c8177f
Autor:
Petra Hoffmann, Irina Fink, Rüdiger Eder, Birgitta Ott-Rötzer, Heiko Smetak, Torsten E. Reichert, Katharina Schäffler, Slava Stamova, Philipp Beckhove, Gerrit Spanier
Publikováno v:
Journal of Immunological Methods. 496:113086
Rare subpopulations of tumor antigen-reactive memory T cells, which actively secrete type-1 effector cytokines, particularly TNF-α in situ, possess anti-tumor activity and prognostic relevance. These cells are relevant for cancer immunotherapy; howe
Autor:
Ingrid Hülsmeyer, Heiko Smetak, Matthias F. Haefner, Philipp Beckhove, Denise Bernhardt, Jessica C. Hassel, Juergen Debus, Alexander Enk, Martin Salzmann
Publikováno v:
Journal of Clinical Oncology. 37:e14104-e14104
e14104 Background: Immune checkpoint blockers have dramatically improved the survival of patients (pts) suffering from advanced metastasized melanoma. In pts with melanoma brain metastases (MBM) a combination with radiotherapy (RT) is routinely used.
Autor:
Marc R. Mansour, Ming Wei, Heinz Lubenau, Sébastien Wieckowski, Lilli Podola, Philipp Beckhove, Amine Adda Berkane, Philippe Slos, Klaus M. Breiner, Anne-Lucie Nugues, Albrecht Meichle, Heiko Smetak
Publikováno v:
Cancer Research. 78:733-733
Significant progresses have been achieved recently in cancer vaccines that aim at engaging or reengaging tumor directed T cells, in particular in the rapidly growing field of personalized immunotherapy. Yet novel immunization solutions to produce eff
Autor:
Philippe Slos, Amine Adda Berkane, Marc R. Mansour, Anne-Lucie Nugues, Klaus M. Breiner, Albrecht Meichle, Philipp Beckhove, Ming Wei, Iris Kobl, Lilli Podola, Sébastien Wieckowski, Matthias Schroff, Heinz Lubenau, Heiko Smetak
Publikováno v:
Journal of Clinical Oncology. 36:74-74
74 Background: Significant progresses have been recently achieved in cancer vaccines, yet novel immunization solutions to deliver efficiently tumor-associated antigens to professional antigen-presenting cells, and to overcome the peripheral tolerance
Autor:
Matthias Schroff, Beckhove Philipp, Klaus M. Breiner, Lilli Podola, Heiko Smetak, Heinz Lubenau, Marc Mansour, Albrecht Meichle, Ming Wei, Sébastien Wieckowski, Anne-Lucie Nugues, Philippe Slos, Marco Springer, Iris Kobl, Amine Adda Berkane
Publikováno v:
Molecular Cancer Therapeutics. 17:B196-B196
Significant progress has been achieved recently in cancer vaccines that aim at engaging or reengaging the tumor immunity, in particular in the rapidly growing field of personalized immunotherapy. Yet novel immunization solutions to deliver efficientl